Biomarker-guided trials: Challenges in practice.

Antoniou, M; Kolamunnage-Dona, R; Wason, J; Bathia, R; Billingham, C; Bliss, J M; Brown, L C; Gillman, A; Paul, J; Jorgensen, A L

Antoniou, M; Kolamunnage-Dona, R; Wason, J; Bathia, R; Billingham, C; Bliss, J M; Brown, L C; Gillman, A; Paul, J; Jorgensen, A L.

Afiliación

Antoniou M; University of Liverpool, UK.
Kolamunnage-Dona R; University of Liverpool, UK.
Wason J; Newcastle University and MRC Biostatistics Unit, Cambridge, UK.
Bathia R; MRC Clinical Trials Unit at UCL, UK.
Billingham C; University of Birmingham, UK.
Bliss JM; Institute of Cancer Research, London, UK.
Brown LC; MRC Clinical Trials Unit at UCL, UK.
Gillman A; Institute of Cancer Research, London, UK.
Paul J; University of Glasgow, UK.
Jorgensen AL; University of Liverpool, UK.

Contemp Clin Trials Commun ; 16: 100493, 2019 Dec.

Article en En | MEDLINE | ID: mdl-31788574

Palabras clave

Biomarker; Challenges; Clinical trial; Personalised medicine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Contemp Clin Trials Commun Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google